Coping With Glioblastoma: A Study of Communication Between Physicians, Patients, and Caregivers
Active not recruiting
309 enrolled
MiDura
Active not recruiting
328 enrolled
PASS of Paediatric Patients Initiating Selumetinib
Active not recruiting
124 enrolled
Natural History Study of Patients With Neurofibromatosis Type I
Active not recruiting
259 enrolled
CBF and NCF Changes With Brain Radiation
Active not recruiting
110 enrolled
FLT-PET / MRI Brain Mets
Active not recruiting
30 enrolled
m-ctDNA
Active not recruiting
70 enrolled
GLIOTARG
Active not recruiting
1,000 enrolled
GASTROBRAIN
Active not recruiting
230 enrolled
COLBRAIN
Active not recruiting
700 enrolled
[18F]FET PET for Characterization of Progressive or Recurrent Glioma From Treatment Related Changes
Active not recruiting
400 enrolled
MR Elastography in Intracranial Lesions: Feasibility & Accuracy
Active not recruiting
512 enrolled
A Longitudinal Assessment of Frailty in Young Adult Survivors of Childhood Cancer
Active not recruiting
1,564 enrolled
OligoLung
Active not recruiting
46 enrolled
IMMUNO-IMAGING
Active not recruiting
31 enrolled
A Study to Measure the Effect of Brain Stimulation on Hand Strength and Function in Patients With Brain Tumors
Active not recruiting
60 enrolled
Multi-parametric Biomarker Development to Predict Malignant Conversion in Patients With Neurofibromatosis Type 1
Active not recruiting
80 enrolled
Late Effects After Treatment in Patients With Previously Diagnosed High-Risk Neuroblastoma
Active not recruiting
376 enrolled
Social Emotional Development in Young Children With Cancer
Active not recruiting
119 enrolled
Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma
Active not recruiting
10,000 enrolled
Perioperative Evaluation of Cerebellar Tumors
Active not recruiting
66 enrolled
Genomic Structural Variation in Cancer Susceptibility
Active not recruiting
1,275 enrolled
A Pilot Study Using 18F-DOPA PET-guided Radiotherapy in Gliomas
Active not recruiting
25 enrolled
Seizure Control as a New Metric in Assessing Efficacy of Tumor Treatment in Patients With Low Grade Glioma
Active not recruiting
100 enrolled
Assessment of Optune Therapy for Patients With Newly Diagnosed Glioblastoma Using Advanced MRI
Active not recruiting
60 enrolled
MRI and Blood Biomarkers for the Prediction of Neurocognitive Decline Following Brain Radiation
Active not recruiting
9 enrolled
cNF Natural Hx
Active not recruiting
500 enrolled
Multimodal Machine Learning Characterization of Solid Tumors
Active not recruiting
135 enrolled
Assessing Brain Metabolism Using MRS With Deuterated Glucose
Active not recruiting
80 enrolled
Understanding the Late Effects of Surviving a Pediatric Brain Tumor
Active not recruiting
42 enrolled
Feasibility and Outcomes of 3D-printed External Cranial Orthosis After Craniectomy
Active not recruiting
32 enrolled
Observational Trial of the Impact of Radiation Dose in Children With Brain and Skull Base Tumors.
Active not recruiting
60 enrolled
Parental Decision-Making for Children With Relapsed Neuroblastoma
Active not recruiting
96 enrolled
PRONO-PARAG
Active not recruiting
25 enrolled
DOTATOC PET/CT for Imaging NET Patients
Active not recruiting
800 enrolled
Glutamate Excitotoxicity in Brain Metastases From Lung, Breast and Melanoma Treated With Stereotactic Radiosurgery
Active not recruiting
100 enrolled
Non-interventional Study of Patients With PN NF1 Starting Selumetinib in Russia
Active not recruiting
150 enrolled
Modifiers of Disease Severity in Cerebral Cavernous Malformations
Active not recruiting
800 enrolled
Tempus Priority Study: A Pan-tumor Observational Study
Active not recruiting
1,000 enrolled
Metabolomic and Epigenetic Profiling of Bodyfluids From Lung and Brain Cancer Receiving Radiation Therapy
Active not recruiting
273 enrolled
GBM-FLUX2
Active not recruiting
2 enrolled
STEREOMIC
Active not recruiting
372 enrolled
Neuroblastoma Precision Trial
Active not recruiting
93 enrolled
Machine Learning to Predict Factors Affecting Rehabilitation Length of Stay and Healthcare Costs for Neurological Rehabilitation
Active not recruiting
10,000 enrolled
Patient-derived Glioma Stem Cell Organoids
Active not recruiting
60 enrolled
VOVS
Active not recruiting
155 enrolled
EC-AIM Brain
Active not recruiting
225 enrolled
SIND
Active not recruiting
52 enrolled
MERLIN_001
Active not recruiting
1,820 enrolled
A Retrospective Study of the Efficacy and Safety of Lolatinib in ALK+ NSCLC Patients With Brain or Meningeal Metastasis
Active not recruiting
28 enrolled